Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: Liver health and dementia in an Italian older population: Findings from the Salus in Apulia study.
Lampignano L, Donghia R, Griseta C, Lagravinese G, Sciarra S, Zupo R, Castellana F, Bortone I, Guerra V, Tirelli S, De Nucci S, Tatoli R, Lozupone M, Sborgia G, Leo A, De Pergola G, Giannelli G, Panza F, Sardone R. Lampignano L, et al. Among authors: lozupone m. Front Aging Neurosci. 2023 Mar 28;15:1187003. doi: 10.3389/fnagi.2023.1187003. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37056690 Free PMC article.
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.
Bertolino A, Taurisano P, Pisciotta NM, Blasi G, Fazio L, Romano R, Gelao B, Lo Bianco L, Lozupone M, Di Giorgio A, Caforio G, Sambataro F, Niccoli-Asabella A, Papp A, Ursini G, Sinibaldi L, Popolizio T, Sadee W, Rubini G. Bertolino A, et al. Among authors: lozupone m. PLoS One. 2010 Feb 22;5(2):e9348. doi: 10.1371/journal.pone.0009348. PLoS One. 2010. PMID: 20179754 Free PMC article.
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G. Panza F, et al. Among authors: lozupone m. Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21. Expert Opin Pharmacother. 2015. PMID: 26389682 Review.
Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?
Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Santamato A, Lozupone M, Capozzo R, Prete C, Pilotto A, Greco A, Logroscino G. Panza F, et al. Among authors: lozupone m. Expert Opin Pharmacother. 2016;17(4):457-61. doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15. Expert Opin Pharmacother. 2016. PMID: 26809554 No abstract available.
Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?
Veneziani F, Panza F, Solfrizzi V, Capozzo R, Barulli MR, Leo A, Lozupone M, Fontana A, Arcuti S, Copetti M, Cardinali V, Grasso A, Tursi M, Iurillo A, Imbimbo BP, Seripa D, Logroscino G. Veneziani F, et al. Among authors: lozupone m. Int Psychogeriatr. 2016 Jul;28(7):1111-24. doi: 10.1017/S1041610216000041. Epub 2016 Jan 28. Int Psychogeriatr. 2016. PMID: 26817511
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.
Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Lozupone M, Leo A, Sardone R, Gagliardi G, Lofano L, Creanza BC, Bisceglia P, Daniele A, Bellomo A, Greco A, Logroscino G. Panza F, et al. Among authors: lozupone m. Expert Opin Emerg Drugs. 2016 Dec;21(4):377-391. doi: 10.1080/14728214.2016.1241232. Epub 2016 Oct 6. Expert Opin Emerg Drugs. 2016. PMID: 27678025 Review.
139 results